LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek Healthcare Awards

BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma Product Launch (Non-OTC)” at this year’s PRWeek Healthcare Awards on May 21. This award is for the partnership with Menarini Stemline from the 2023 launch of ORSERDU® (elacestrant) for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast can